abstract |
In accordance with the present invention, compounds that inhibit post-transcriptional expression of VEGF and methods for using them are provided. In one aspect of the invention, compounds are provided that are useful in inhibiting VEGF production, inhibiting angiogenesis, and / or treating cancer, diabetic retinopathy or exudative macular degeneration. In another aspect of the invention, there are provided methods for inhibiting VEGF production, inhibiting angiogenesis, and / or treating cancer, diabetic retinopathy or exudative macular degeneration using the compounds of the invention. |